| Line Item | 2024-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.9M | +7.5% | +27.1% |
| Cost of Revenue | $7.0M | +25.5% | +11.6% |
| R&D Expense | $2.9M | -30.0% | -66.1% |
| SG&A Expense | $16.7M | +41.2% | -18.5% |
| Operating Income | -$17.8M | -27.2% | +43.2% |
| Pre-tax Income | -$16.9M | -24.2% | +45.1% |
| Income Tax | $0 |
| Line Item | 2024-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $87.5M | -19.5% | -27.0% |
| Accounts Receivable | $12.7M | +63.2% | +48.2% |
| Inventory | $11.7M | +12.1% | -46.2% |
| Current Assets | $171.0M | -15.7% | -30.1% |
| Total Assets | $230.5M | -12.5% | -17.1% |
| Current Liabilities |
| Line Item | 2024-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.5M | -43.0% | — |
| Capital Expenditures | $40K | +300.0% | — |
| Investing Cash Flow | $59.2M | +31.2% | — |
| Financing Cash Flow | -$22.0M | — | — |
| Free Cash Flow | -$44.5M | -43.1% | — |
| -100.0% |
| — |
| Net Income | -$16.9M | -24.2% | +45.1% |
| EPS (Basic) | -$0.11 | -22.2% | +47.6% |
| EPS (Diluted) | -$0.11 | -22.2% | +47.6% |
| $60.2M |
| -21.1% |
| +2.6% |
| Total Liabilities | $87.9M | -17.1% | -3.4% |
| Stockholders' Equity | $142.6M | -9.5% | -23.7% |